Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C? but not seen in other diseases

International Journal of Molecular Medicine

Volumn 2, Issue 1, 1998, Pages 51-56

  Kuratsune, Hirohiko ^a,b   Yamaguti, Kouzi ^a   Lindh, Gudrun ^c   Evengård, Birgitta ^c   Takahashi, Mamoru ^d   Machii, Takashi ^a   Matsumura, Kiyoshi ^b,e   Takaishi, Joh ^a   Kawata, Sumio ^a   Långström, Bengt ^b,f   Kanakura, Yuzuru ^a   Kitani, Teruo ^a,g   Watanabe, Yasuyoshi ^b,e  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ASAHI CHEMICAL INDUSTRY CO   (Japan)

^e OSAKA BIOSCIENCE INSTITUTE   (Japan)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g SAKAI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Acylcarnitine; Chronic fatigue syndrome; Chronic hepatitis (type C); Free carnitine; Race

Indexed keywords

ACYLCARNITINE; CARNITINE; DRUG DERIVATIVE; GALACTOSAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC FATIGUE SYNDROME; CHRONIC HEPATITIS C; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTENSION; JAPANESE (PEOPLE); LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWEDISH CITIZEN; ACUTE DISEASE; ANIMAL; BLOOD; C3H MOUSE; ETHNOLOGY; HEPATITIS C; JAPAN; METABOLISM; NEOPLASM; SWEDEN; TOXIC HEPATITIS;

ACUTE DISEASE; ANIMALS; CARNITINE; DIABETES MELLITUS; FATIGUE SYNDROME, CHRONIC; FEMALE; GALACTOSAMINE; HEPATITIS C, CHRONIC; HEPATITIS, TOXIC; HUMANS; JAPAN; MALE; MICE; MICE, INBRED C3H; NEOPLASMS; SWEDEN;

EID: 0032107070     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2.1.51     Document Type: Article

References (36)

1. Holmes GP, Kaplan JE, Gantz NM, et al: Chronic fatigue syndrome: a working case definition. Ann Intern Med 108: 387-389, 1988.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A and International Chronic Fatigue Syndrome Study Group: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121: 953-959, 1994.
3. Rebouche CJ and Engel AG: Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 58: 533-540, 1983.
4. Gilbert EF: Carnitine deficiency. Pathology 17: 161-171, 1985.
5. Kendler BS: Carnitine: an overview of its role in preventive medicine. Prev Med 15: 373-390, 1986.
6. Rebouche CJ and Paulson DJ: Carnitine metabolism and function in humans. Annu Rev Nutr 6: 41-66, 1986.
7. Winter SC, Szabo Aczel S, Curry CJ, Hutchinson HT, Hogue R and Shug A: Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141: 660-665, 1987.
8. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S and Kitani T: Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 18: S62-S67, 1994.
9. Kuratsune H, Yamaguti K, Takahashi M, Tagawa S, Machii T and Kitani T: Abnormal cellular carnitine metabolism in chronic fatigue syndrome. EOS J Immunol Immunopharmacol 15: 40-44, 1995.
10. Kuratsune H, Yamaguti K, Watanabe Y, Takahashi M, Nakamoto I, Machii T, Jacobsson G, Onoe H, Matsumura K, Valind S, Långström B and Kitani T: Acylcarnitine and chronic fatigue syndrome. In: Carnitine Today. Molecular Biology Intelligence Unit. De Simone C and Famularp G (eds). Landes Bioscience, Austin, TX, ppl95-213, 1997.
11. Bartlett K, Bhuiyan AK, Aynsley Green A, Butler PC and Alberti KG: Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine. Clin Sei 77: 413-416, 1989.
12. uC]acetyl-L-carnitine, and L-["C]carnitine labelled in specific positions, applied in PET studies on rhesus monkey. Nucl Med Biol 21: 1067-1073, 1997.
13. Yamaguti K, Kuratsune H, Watanabe Y, Takahashi M, Nakamoto I, Machii T, Jacobsson G, Onoe H, Matsumura K, Valind S, Långström B and Kitani T: Acylcarnitine metabolism during fasting and after refeeding. Biochem Biophys Res Commun 225: 740-746, 1996.
14. Burlina AP, Sershen H, Dehler EA and Lajtha A: Uptake of acetyl-L-carnitine in the brain. Neurochem Res 14: 489-493, 1989.
15. Farrell S, Vogel J and Bieber LL: Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta 876: 175-177, 1986.
16. Kuratsune H, Watanabe Y, Yamaguti K, Jacobsson G, Takahashi M, Machii T, Onoe H, Onoe K, Matsumura K, Valind S, Kitani T and Långström B: High uptake of [2-"C] acetyl-L-carnitine into the brain: a PET study. Biochem Biophys Res Commun 231: 488-493, 1997.
17. Ghirardi O, Milano S, Ramacci MT and Angelucci L: Effect of acetyl-1-carnitine chronic treatment on discrimination models in aged rats. Physiol Behav 44: 769-773, 1988.
18. 3IP and 'H NMR spectroscopy. Brain Res 526: 108-112, 1990.
19. Aureli T, Miccheli A, Di Cocco ME, Ghirardi O, Giuliani A, Ramacci MT and Conti F: Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat - study by 13P- and 1H-NMR spectroscopy. Brain Res 643: 92-99, 1994.
20. Pascale A, Milano S, Corsico N, Lucchi L, Battaini F, Martelli EA, Trabucchi M and Govoni S: Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: in vitro and in vivo studies. Eur J Pharmacol 265: 1-7, 1994.
21. Foreman PJ, Perez Polo JR, Angelucci L, Ramacci MT and Taglialatela G: Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats. Prog Neuro-psychopharmacol Biol Psychiatry 19: 117-133, 1995.
22. Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN and McClure RJ: Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 16: 1-4, 1995.
23. Takahashi M, Ueda S, Misaki H, Sugiyama N, Matsumoto K, Matsuo N and Murao S: Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 40: 817-821, 1994.
24. Plioplys AV and Plioplys S: Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 32: 132-138, 1995.
25. Majeed T, De Simone C, Famularo G, Marcellini S and Benan PO: Abnormalities of carnitine metabolism in chronic fatigue syndrome. Eur J Neurol 2: 425-428, 1995.
26. Fukazawa T, Sasaki H, Kikuchi S, Hamada T and Tashiro K: Serum carnitine and disabling fatigue in multiple sclerosis. Psychiatr Clin Neurosci 50: 323-325, 1996.
27. Matthews DA, Lane TJ and Manu P: Definition of the chronic fatigue syndrome. Ann Intern Med 109: 511-512, 1988.
28. Holmes GP, Kaplan JE, Schonberger LB, et al: Definition of the chronic fatigue syndrome. Author's response. Ann Intern Med 109:512, 1988.
29. Krahenbuhl S and Reichen J: Carnitine metabolism in patients with chronic liver disease. Hepatology 25: 148-153, 1997.
30. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M and Yoshioka K: Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 108: 138-143, 1997.
31. Famularo G, Moretti S, Marcellini S, Trinchieri V, Tzantzoglou S, Santini G, Longo A and De Simone C: Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 11: 185-190, 1997.
32. Stevens MJ, Lattimer SA, Feldman EL, Helton ED, Millington DS, Sima AA and Greene DA: Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. Metabolism 45: 865-872, 1996.
33. Cossarizza A, Mussini C, Mongiardo N, Borghi V, Sabbatini A, De Rienzo B and Franceschi C: Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 11: 19-26, 1997.
34. Kuratsune H, Yamaguti K, Sawada M, et al: Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1: 143-146, 1998.
35. Yamada J, Sakuma M and Suga T: Induction of peroxisomal beta-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochim Biophys Acta 1137: 231-236, 1992.
36. Chiu KM, Schmidt MJ, Shug AL, Binkley N and Gravenstein S: Effect of dehydroepiandrosterone sulfate on carnitine acetyl transferase activity and L-carnitine levels in oophorectomized rats. Biochim Biophys Acta 1344: 201-209, 1997.